Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
Omalizumab in Moderate to Severe Allergic Asthma Patients | JAA - Dove Medical Press
+ 11 more
6/19/23 at 8:19am
Organization
Dovepress.com
Author
Dove Press
34 words
0
Comments
Evaluating the safety and effectiveness of omalizumab in a real-world setting in patients with moderate to severe allergic asthma in China
Respiratory Conditions
Health
Omalizumab
Dove Medical Press
China
You are the first to view
https://www.dovepress.com/real-world-safety-and-effectiveness-of-omalizumab-in-moderate-to-sever-peer-reviewed-fulltext-article-JAA
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...